Please provide your email address to receive an email when new articles are posted on . Outset Medical, maker of the Tablo hemodialysis machine, reported that the device was added to 30 new hospital ...

Please provide your email address to receive an email when new articles are posted on . A lengthy review by the FDA of 510(k)-related updates to Outset Medical’s Tablo home dialysis machine has halted ...

Outset Medical has raised $76.5 million in a series C round led by T. Rowe Price Associates. In addition to new investor T. Rowe Price Associates, existing investors Fidelity Management & Research ...

About a month and a half after pausing shipments of its Tablo hemodialysis system for at-home use, Outset Medical has secured the renewed FDA clearance it was waiting for, greenlighting new sales of ...

Outset Medical, Inc. (NASDAQ:OM) is commercializing a new hemodialysis machine for acute care and home settings. I previously wrote about OM with a Hold outlook. The company has reduced guidance due ...

Outset Medical (OM) has received a new Buy rating, initiated by BTIG analyst, Marie Thibault. Marie Thibault’s rating is based on a variety of positive indicators for Outset Medical, despite some ...

NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Outset Medical, Inc. (“Outset ...

Dialysis tech company Outset Medical appears to have put the cart before the horse, so to speak. The "cart" in this case being quite literal – the TabloCart – and the "horse" being metaphorical for ...

Outset Medical (NASDAQ:OM), the innovator behind the Tablo Hemodialysis System, reported fourth-quarter earnings on Wednesday, Feb. 19, that topped analysts' consensus expectations on top and bottom ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”) announced today that the Strategic Acquisition Center (SAC) Office of Procurement, Department of Veterans Affairs ...